Niraparib

Niraparib is a medication used to treat certain types of ovarian, fallopian tube, or primary peritoneal cancers, especially in patients with specific genetic mutations called BRCA mutations. It works by blocking an enzyme involved in repairing damaged DNA in cancer cells. This prevention of DNA repair makes cancer cells more likely to die, slowing or stopping tumor growth. Typically taken as a daily pill, niraparib helps extend the time patients remain free from disease progression, offering a targeted therapy option for those with specific genetic profiles.